The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Cymbalta (duloxetine) is effective to
improve cognition in individuals with Mild Cognitive Impairment.
Phase:
Phase 4
Details
Lead Sponsor:
University of North Texas Health Science Center
Treatments:
Duloxetine Hydrochloride Serotonin and Noradrenaline Reuptake Inhibitors